amaxa pharma ltd

2.5

amaxa pharma ltd Company Information

Share AMAXA PHARMA LTD
Live 
EstablishedSmallDeclining

Company Number

08102507

Registered Address

73 great peter street, london, SW1P 2BN

Industry

Other personal service activities n.e.c.

 

Telephone

02074675342

Next Accounts Due

March 2025

Group Structure

View All

Directors

Vladimir Tkachenko7 Years

Shareholders

vladimir tkachenko 100%

amaxa pharma ltd Estimated Valuation

£1.2m

Pomanda estimates the enterprise value of AMAXA PHARMA LTD at £1.2m based on a Turnover of £2m and 0.62x industry multiple (adjusted for size and gross margin).

amaxa pharma ltd Estimated Valuation

£254.6k

Pomanda estimates the enterprise value of AMAXA PHARMA LTD at £254.6k based on an EBITDA of £56.2k and a 4.53x industry multiple (adjusted for size and gross margin).

amaxa pharma ltd Estimated Valuation

£569k

Pomanda estimates the enterprise value of AMAXA PHARMA LTD at £569k based on Net Assets of £190.4k and 2.99x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Amaxa Pharma Ltd AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Amaxa Pharma Ltd Overview

Amaxa Pharma Ltd is a live company located in london, SW1P 2BN with a Companies House number of 08102507. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in June 2012, it's largest shareholder is vladimir tkachenko with a 100% stake. Amaxa Pharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £2m with declining growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Amaxa Pharma Ltd Health Check

Pomanda's financial health check has awarded Amaxa Pharma Ltd a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2.5out of 5
positive_score

3 Strong

positive_score

1 Regular

positive_score

6 Weak

size

Size

annual sales of £2m, make it larger than the average company (£849k)

£2m - Amaxa Pharma Ltd

£849k - Industry AVG

growth

Growth

3 year (CAGR) sales growth of -39%, show it is growing at a slower rate (5.7%)

-39% - Amaxa Pharma Ltd

5.7% - Industry AVG

production

Production

with a gross margin of 20%, this company has a higher cost of product (41.1%)

20% - Amaxa Pharma Ltd

41.1% - Industry AVG

profitability

Profitability

an operating margin of 2.9% make it less profitable than the average company (6.5%)

2.9% - Amaxa Pharma Ltd

6.5% - Industry AVG

employees

Employees

with 1 employees, this is below the industry average (14)

1 - Amaxa Pharma Ltd

14 - Industry AVG

paystructure

Pay Structure

on an average salary of £30.3k, the company has an equivalent pay structure (£30.3k)

£30.3k - Amaxa Pharma Ltd

£30.3k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £2m, this is more efficient (£82.8k)

£2m - Amaxa Pharma Ltd

£82.8k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 132 days, this is later than average (28 days)

132 days - Amaxa Pharma Ltd

28 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 140 days, this is slower than average (40 days)

140 days - Amaxa Pharma Ltd

40 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Amaxa Pharma Ltd

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Amaxa Pharma Ltd

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 76.1%, this is a higher level of debt than the average (43.1%)

76.1% - Amaxa Pharma Ltd

43.1% - Industry AVG

amaxa pharma ltd Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for amaxa pharma ltd. Get real-time insights into amaxa pharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Amaxa Pharma Ltd Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for amaxa pharma ltd by selecting its closest rivals and benchmarking them against 12 key performance metrics.

amaxa pharma ltd Ownership

AMAXA PHARMA LTD group structure

Amaxa Pharma Ltd has no subsidiary companies.

Ultimate parent company

AMAXA PHARMA LTD

08102507

AMAXA PHARMA LTD Shareholders

vladimir tkachenko 100%

amaxa pharma ltd directors

Amaxa Pharma Ltd currently has 1 director, Mr Vladimir Tkachenko serving since Mar 2017.

officercountryagestartendrole
Mr Vladimir TkachenkoEngland52 years Mar 2017- Director

AMAXA PHARMA LTD financials

EXPORTms excel logo

Amaxa Pharma Ltd's latest turnover from June 2023 is estimated at £2 million and the company has net assets of £190.4 thousand. According to their latest financial statements, Amaxa Pharma Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013
Turnover1,969,9982,300,9095,279,9498,833,1126,870,1444,038,4994,450,7402,917,5243,083,6421,377,3311,021,899
Other Income Or Grants00000000000
Cost Of Sales1,575,3031,858,7094,349,0897,090,3425,528,5443,231,6163,532,2242,285,1112,399,8331,087,287792,671
Gross Profit394,694442,201930,8611,742,7711,341,600806,883918,517632,413683,809290,045229,227
Admin Expenses338,448980,275807,3491,632,7501,199,362709,487848,648592,923541,855247,993186,025
Operating Profit56,246-538,074123,512110,021142,23897,39669,86939,490141,95442,05243,202
Interest Payable00000000000
Interest Receivable1,9042,5224321,26811,5014,5862,0305,5226,0534,8882,213
Pre-Tax Profit58,150-535,552123,944111,289153,739101,98271,89945,012148,00746,94045,416
Tax-14,5370-23,549-21,145-29,210-19,377-13,661-9,002-29,601-9,857-10,446
Profit After Tax43,612-535,552100,39590,144124,52982,60658,23836,010118,40537,08334,970
Dividends Paid00000000000
Retained Profit43,612-535,552100,39590,144124,52982,60658,23836,010118,40537,08334,970
Employee Costs30,30828,71127,69426,44053,87625,85324,83153,355502,937211,289183,878
Number Of Employees111121121987
EBITDA*56,246-517,146145,259132,567171,337126,44594,18380,549141,95442,05243,202

* Earnings Before Interest, Tax, Depreciation and Amortisation

Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013
Tangible Assets83,7180000000000
Intangible Assets0104,648130,493210,812233,359267,369267,38773,970000
Investments & Other00000000000
Debtors (Due After 1 year)00000000000
Total Fixed Assets83,719104,648130,493210,812233,359267,369267,38773,970000
Stock & work in progress00000000000
Trade Debtors714,168907,4492,173,4743,206,6462,165,1051,302,6171,488,986814,416394,57653,0777,059
Group Debtors00000000000
Misc Debtors013,52310,95834,04011,902134,55511,80758,298000
Cash076,165327,397537,2391,999,2321,067,816766,701857,3341,351,5191,069,739885,397
misc current assets00000000000
total current assets714,168997,1372,511,8303,777,9264,176,2392,507,7412,267,4941,730,0491,746,0961,122,817892,456
total assets797,8861,101,7862,642,3233,988,7384,409,5982,775,1102,534,8811,804,0191,746,0961,122,817892,456
Bank overdraft00000000000
Bank loan00000000000
Trade Creditors 607,446835,4261,813,4892,919,6703,424,0891,921,8962,051,8181,552,4401,554,5651,049,783856,238
Group/Directors Accounts00000000000
other short term finances00000000000
hp & lease commitments00000000000
other current liabilities0118,463145,344486,007492,591475,082197,28224,017000
total current liabilities607,446953,8901,958,8333,405,6773,916,6812,406,7022,249,1011,576,4571,554,5651,049,783856,238
loans00000000000
hp & lease commitments00000000000
Accruals and Deferred Income00000000000
other liabilities00000000000
provisions00000000000
total long term liabilities00000000000
total liabilities607,446953,8901,958,8333,405,6773,916,6812,406,7022,249,1011,576,4571,554,5651,049,783856,238
net assets190,440147,896683,490583,061492,917368,408285,781227,562191,53173,03336,218
total shareholders funds190,440147,896683,490583,061492,917368,408285,781227,562191,53173,03336,218
Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017Jun 2016Jun 2015Jun 2014Jun 2013
Operating Activities
Operating Profit56,246-538,074123,512110,021142,23897,39669,86939,490141,95442,05243,202
Depreciation00000000000
Amortisation020,92821,74722,54629,09929,04924,31441,059000
Tax-14,5370-23,549-21,145-29,210-19,377-13,661-9,002-29,601-9,857-10,446
Stock00000000000
Debtors-206,805-1,263,460-1,056,2541,063,679765,959-89,745628,078478,139341,49946,0187,059
Creditors-227,980-978,062-1,106,181-504,4201,502,193-129,922499,378-2,125504,782193,545856,238
Accruals and Deferred Income-118,463-26,881-340,663-6,58417,509277,800173,26524,017000
Deferred Taxes & Provisions00000000000
Cash flow from operations-97,929-258,629-268,880-1,463,261895,870344,691125,087-384,700275,636179,722881,935
Investing Activities
capital expenditure20,9304,91758,57214,911-29,032-217,731-115,029000
Change in Investments00000000000
cash flow from investments20,9304,91758,57214,911-29,032-217,731-115,029000
Financing Activities
Bank loans00000000000
Group/Directors Accounts00000000000
Other Short Term Loans 00000000000
Long term loans00000000000
Hire Purchase and Lease Commitments00000000000
other long term liabilities00000000000
share issue-1,068-42340-2122-192192-2681,248
interest1,9042,5224321,26811,5014,5862,0305,5226,0534,8882,213
cash flow from financing8362,4804661,26811,4804,6082,0115,5436,1454,6203,461
cash and cash equivalents
cash-76,165-251,232-209,842-1,461,993931,416301,115-90,633-494,186281,780184,342885,397
overdraft00000000000
change in cash-76,165-251,232-209,842-1,461,993931,416301,115-90,633-494,186281,780184,342885,397

P&L

June 2023

turnover

2m

-14%

operating profit

56.2k

0%

gross margin

20.1%

+4.25%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2023

net assets

190.4k

+0.29%

total assets

797.9k

-0.28%

cash

0

-1%

net assets

Total assets minus all liabilities

amaxa pharma ltd company details

company number

08102507

Type

Private limited with Share Capital

industry

96090 - Other personal service activities n.e.c.

incorporation date

June 2012

age

12

accounts

Micro-Entity Accounts

ultimate parent company

None

previous names

N/A

incorporated

UK

address

73 great peter street, london, SW1P 2BN

last accounts submitted

June 2023

amaxa pharma ltd Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to amaxa pharma ltd.

charges

amaxa pharma ltd Companies House Filings - See Documents

datedescriptionview/download